The market for musculosketal drugs equates to about 14% of the pharma total and is growing at over 7% year on year. Many musculosketal disorders are incurable so that patients will take these pain- and inflammation-reducing drugs either continuously or periodically for life. As their incidence is age-related, the increase in the size of the aging population is one factor driving the growth.

The world market for drugs that treat diseases such as arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome and muscular dystrophy has been growing at more than 7% a year since 2012 and is predicted to go on growing at a slightly faster rate to 2020.

Many musculosketal disorders are incurable so that patients will take these pain- and i..

View more at https://www.1888pressrelease.com/increasing-global-obesity-and-stress-levels-mean-rapid-growt-pr-622754.html